Miami Cardiac and Vascular Institute Grand Rounds: Pulmonary Thromboendarterectomy
Progressive pulmonary hypertension ensues, with substantial associated morbidity and mortality. Despite advances in medical therapy for some types of pulmonary hypertension, surgical pulmonary endarterectomy, also referred to as pulmonary thromboendarterectomy, remains the only potentially curative option for patients with chronic thromboembolic pulmonary hypertension.
Join Dr. Yoshiya Toyoda as he discusses potential causes of pulmonary hypertension, medical options, and effective patient selection for surgical treatment.
|Live- Baptist Hospital 5MCVI|
Cardiologists, Interventional Cardiologists, Cardiothoracic Surgeons, Interventional Radiologists, Pulmonologists, Hematologists, General Internists, Primary Care Physicians, Intensivist, General Surgeons, Anesthesiologists, Emergency Medicine Physicians, Hospitalists, Nurses and other interested healthcare providers.
- Summarize the wide range of potential causes for pulmonary hypertension.
- Assess surgical treatment options for each group of pulmonary hypertension, with special attention to chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy surgery.
- Effectively identify patients who will benefit from pulmonary thromboendarterectomy surgery.
Yoshiya Toyoda, M.D., Ph.D.
William Maul Measey Professor of Surgery
Chief, Division of Cardiovascular Surgery
Director, Mechanical Circulatory Support
Surgical Director, Thoracic Transplantation
Temple University School of Medicine
Yoshiya Toyoda, M.D indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
MCVI Planning Committee Members Disclosures:
James Benenati, M.D., indicated that he is a consultant for Penumbra and Bard. He is also a stock shareholder for Penumbra and Scientia. Barry Katzen, M.D. has indicated that he is a consultant for Boston Scientific, Phillips Medical, W.L. Gore and Bard. Dr. Theodore Feldman has indicated that he is a member of the Speakers’ Bureau for Regeneron, Sanofi, Boehringer Ingeldeim, and Novartis.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 2 credit hour, CE Broker Course #20-707238, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 2 credit hour for Nurse Practitioners and Nurses.. Baptist Health South Florida CE Broker Provider #50-182.
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Florida Board of Nursing
- 2.00 Nurse Practitioners
- 2.00 General certificate of attendance
Pre-registration is required. Please log in to register.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.